What are the treatment and prevention options for cluster headaches?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cluster Headache Treatment and Prevention

For cluster headache treatment, subcutaneous sumatriptan (6 mg) or high-flow oxygen therapy (100% oxygen at 12-15 L/min via non-rebreather mask for at least 15 minutes) should be used as first-line abortive treatments, while galcanezumab is recommended for prevention of episodic cluster headache only. 1, 2

Acute Treatment Options

  • Subcutaneous sumatriptan (6 mg) is recommended for the short-term treatment of cluster headache attacks, with clinical trials showing pain relief in 74% of attacks within 15 minutes compared to 26% with placebo 3, 4, 5
  • Intranasal zolmitriptan (10 mg) is an effective alternative first-line option for acute treatment 3, 1
  • High-flow normobaric oxygen therapy (100% oxygen at 12-15 L/min via non-rebreather mask for 15 minutes) is strongly recommended as a first-line abortive treatment with several advantages: no side effects, no contraindications, and can be used multiple times daily 3, 1, 2, 6
  • Recent research shows that home oxygen concentrators can be an effective alternative to oxygen tanks, with better pain relief than oral zolmitriptan and no reported adverse events 7
  • Non-invasive vagus nerve stimulation is suggested for the short-term treatment of episodic cluster headache when pharmacologic treatments fail or are contraindicated 1, 2

Preventive Treatment Options

For Episodic Cluster Headache

  • Galcanezumab is recommended as first-line prophylactic treatment for episodic cluster headache (weak recommendation for) 3, 1
  • There is insufficient evidence to recommend for or against verapamil for the prevention of episodic cluster headache, though it is commonly used in clinical practice (at least 240 mg daily) 3, 1

For Chronic Cluster Headache

  • Galcanezumab is not recommended for prevention of chronic cluster headache (weak recommendation against) 3, 1
  • There is insufficient evidence to recommend for or against verapamil for chronic cluster headache prevention 3, 1
  • For treatment-refractory chronic cluster headache, occipital nerve stimulation may be considered based on clinical trial data 8

Bridging Therapy

  • Corticosteroids (oral prednisolone or suboccipital injections) are commonly used as bridge treatments until preventive medications take effect 8, 9
  • These treatments help manage symptoms during the period when long-term preventives are building efficacy 8

Important Considerations and Monitoring

  • Monitor frequency of sumatriptan use to prevent medication overuse headache 2
  • Implantable sphenopalatine ganglion stimulator is not recommended for cluster headache treatment (weak recommendation against) 1
  • The efficacy of subcutaneous sumatriptan has been demonstrated in long-term use without evidence of tachyphylaxis over 3 months of treatment 5
  • For patients with frequent attacks, consider preventive medications alongside acute treatments to reduce attack frequency and severity 2, 8

Treatment Algorithm

  1. For acute attacks:

    • First-line: Subcutaneous sumatriptan 6 mg OR high-flow oxygen (100% at 12-15 L/min) 3, 1, 2
    • Alternative: Intranasal zolmitriptan 10 mg if first-line options are unavailable or contraindicated 3, 1
  2. For prevention:

    • Episodic cluster headache: Galcanezumab 3, 1
    • Chronic cluster headache: Consider verapamil (despite insufficient evidence) 1, 8
    • Bridge therapy with corticosteroids while waiting for preventive medications to take effect 8
  3. For treatment-refractory cases:

    • Consider neuromodulation options such as non-invasive vagus nerve stimulation or occipital nerve stimulation 1, 8

References

Guideline

Cluster Headache Prevention and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Initial Treatment for Cluster Headache

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Treatment of cluster headache: clinical trials, design and results.

Cephalalgia : an international journal of headache, 1995

Research

Management of cluster headache: Treatments and their mechanisms.

Cephalalgia : an international journal of headache, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.